Health IT Issues That Deserve a Second Read
Health IT Issues recently cited Clincierge CEO Scott Gray‘s article Modernizing Clinical Trials in 2023 with Patient Centricity as one of the most-read thought leader posts for December 2022.
patient recruitment
Improving Pediatric Clinical Trial Development in 2023
Clincierge CEO Scott Gray shares his experiences and best practices for providing patient concierge support services to pediatric clinical trial patients and their caregivers in this new Clinical Research News article.
Drug Discovery Predictions: Analysis and Insight
In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.
Modernizing Clinical Trials in 2023 with Patient Centricity
In this Health IT Answers article, Scott Gray, CEO, discusses modern patient-centric methods to remove barriers and increase access in rare disease clinical trials, such as prioritizing patient engagement, embracing digital solutions, and investing in supplemental patient support services.
Amplifying the Voice of the Patient in Rare Disease Trials
Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …
Amplifying the Voice of the Patient in Rare Disease Trials Read More »
The Business Case for Patient Experience
Featured in Clinical Researcher: Scott Gray, CEO, discusses the business case for patient experience, including the patient’s role in clinical trial return on investment (ROI), the benefits of patient centricity, and investing in patient experience.
PharmaVoice 100 DE&I Champions: Scott Gray
PharmaVoice 100 award recipient, Scott Gray, CEO, founder, and president of Clincierge is championing diversity, equity, and inclusion (DEI) within the company and beyond.
Clincierge CEO Scott Gray Named to PharmaVoice 100
PHILADELPHIA, Sept. 6, 2022 /PRNewswire/ — Clincierge CEO Scott Gray has been named to the PharmaVoice 100, an annual list recognizing the most inspiring people in life sciences.
Scott Gray Named 2022 Philadelphia Titan 100
PHILADELPHIA, July 5, 2022 – Titan CEO and headline sponsor Wipfli LLP are pleased to announce the 2022 Philadelphia Titan 100. The Titan 100 program recognizes Philadelphia’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion.
A Hybrid Approach to Decentralized Trials
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
